Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.5943
-0.0287 (-4.60%)
Feb 6, 2026, 4:00 PM EST - Market closed
Vaxart Employees
Vaxart had 105 employees as of December 31, 2024. The number of employees decreased by 4 or -3.67% compared to the previous year.
Employees
105
Change (1Y)
-4
Growth (1Y)
-3.67%
Revenue / Employee
$1,411,467
Profits / Employee
-$482,886
Market Cap
142.63M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 105 | -4 | -3.67% |
| Dec 31, 2023 | 109 | -55 | -33.54% |
| Dec 31, 2022 | 164 | 54 | 49.09% |
| Dec 31, 2021 | 110 | 82 | 292.86% |
| Dec 31, 2020 | 28 | 14 | 100.00% |
| Sep 30, 2020 | 30 | 2 | 7.14% |
| Jun 30, 2020 | 16 | -17 | -51.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 159 |
| Caribou Biosciences | 147 |
| Rani Therapeutics Holdings | 106 |
| Nkarta | 105 |
| Connect Biopharma Holdings | 62 |
| Acumen Pharmaceuticals | 61 |
| Elicio Therapeutics | 32 |
| Corbus Pharmaceuticals Holdings | 28 |
VXRT News
- 4 weeks ago - Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - GlobeNewsWire
- 2 months ago - Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript - Seeking Alpha
- 3 months ago - Vaxart, Inc. (VXRT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Vaxart to Host Upcoming Conference Calls - GlobeNewsWire
- 3 months ago - Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program - PRNewsWire
- 3 months ago - Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program - PRNewsWire
- 4 months ago - Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025 - GlobeNewsWire
- 5 months ago - Vaxart Appoints W. Mark Watson as Lead Independent Director - GlobeNewsWire